CD79A and cancer: The metabolic pathways of different substances are mainly enriched in five pathways including pathways in cancer and intestinal immune network for Immunoglobulin A (IgA) production and alpa-Linolenic acid metabolism and small-cell lung cancer and interleukin17 (IL-17)–producing T helper (Th17) cell differentiation.